Anthony Lau

Anthony Lau

Auto-generated profile, based on publicly available information

Anthony Lau

Garvan Institute of Medical Research

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DADanielle T. Avery
Danielle T. Avery
AKAlisa Kane
Alisa Kane
TNTina Nguyen
Tina Nguyen
ALAnthony Lau
Anthony Lau
ANAkira Nguyen
Akira Nguyen
STStuart G. Tangye
Stuart G. Tangye
Gain-of-function (GOF) mutations in PIK3CD, encoding the p110δ subunit of phosphatidylinositide 3-kinase (PI3K), cause a primary immunodeficiency. Affected individuals display impaired humoral immune responses following infection or immunization. To establish mechanisms underlying these immune defects, we studied a large cohort of patients with PIK3CD GOF mutations and established a novel mouse model using CRISPR/Cas9-mediated gene editing to introduce a common pathogenic mutation in Pik3cd. In both species, hyperactive PI3K severely affected B cell development and differentiation in the bone marrow and the periphery. Furthermore, PI3K GOF B cells exhibited intrinsic defects in class-switch recombination (CSR) due to impaired induction of activation-induced cytidine deaminase (AID) and failure to acquire a plasmablast gene signature and phenotype. Importantly, defects in CSR, AID expression, and Ig secretion were restored by leniolisib, a specific p110δ inhibitor. Our findings reveal key roles for balanced PI3K signaling in B cell development and long-lived humoral immunity and memory and establish the validity of treating affected individuals with p110δ inhibitors.

1 January 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Edwards Emily S.J.Edwards Emily S.J.
Edwards Emily S.J.
JBJulia Bier
Julia Bier
TCTheresa S. Cole
Theresa S. Cole
MWMelanie Wong
Melanie Wong
PHPeter Hsu
Peter Hsu
STStuart G. Tangye
Stuart G. Tangye

4 May 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RWRobert P. Wilson
Robert P. Wilson
MIMegan L. Ives
Megan L. Ives
GRGeetha Rao
Geetha Rao
ALAnthony Lau
Anthony Lau
KPKathryn Payne
Kathryn Payne
EDElissa K. Deenick
Elissa K. Deenick
Unconventional T cells such as γδ T cells, natural killer T cells (NKT cells) and mucosal-associated invariant T cells (MAIT cells) are a major component of the immune system; however, the cytokine signaling pathways that control their development and function in humans are unknown. Primary immunodeficiencies caused by single gene mutations provide a unique opportunity to investigate the role of specific molecules in regulating human lymphocyte development and function. We found that individuals with loss-of-function mutations in STAT3 had reduced numbers of peripheral blood MAIT and NKT but not γδ T cells. Analysis of STAT3 mosaic individuals revealed that this effect was cell intrinsic. Surprisingly, the residual STAT3-deficient MAIT cells expressed normal levels of the transcription factor RORγt. Despite this, they displayed a deficiency in secretion of IL-17A and IL-17F, but were able to secrete normal levels of cytokines such as IFNγ and TNF. The deficiency in MAIT and NKT cells in STAT3-deficient patients was mirrored by loss-of-function mutations in IL12RB1 and IL21R, respectively. Thus, these results reveal for the first time the essential role of STAT3 signaling downstream of IL-23R and IL-21R in controlling human MAIT and NKT cell numbers.

16 December 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ALAnthony Lau
Anthony Lau
DADanielle T. Avery
Danielle T. Avery
KJKatherine Jackson
Katherine Jackson
HLHelen Lenthall
Helen Lenthall
SVstefano volpi
stefano volpi
EDElissa K. Deenick
Elissa K. Deenick
Antibody-mediated autoimmune diseases are a major health burden. However, our understanding of how self-reactive B cells escape self-tolerance checkpoints to secrete pathogenic autoantibodies remains incomplete. Here, we demonstrate that patients with monogenic immune dysregulation caused by gain-of-function mutations in PIK3CD, encoding the p110δ catalytic subunit of phosphoinositide 3-kinase (PI3K), have highly penetrant secretion of autoreactive IgM antibodies. In mice with the corresponding heterozygous Pik3cd activating mutation, self-reactive B cells exhibit a cell-autonomous subversion of their response to self-antigen: instead of becoming tolerized and repressed from secreting autoantibody, Pik3cd gain-of-function B cells are activated by self-antigen to form plasmablasts that secrete high titers of germline-encoded IgM autoantibody and hypermutating germinal center B cells. However, within the germinal center, peripheral tolerance was still enforced, and there was selection against B cells with high affinity for self-antigen. These data show that the strength of PI3K signaling is a key regulator of pregerminal center B cell self-tolerance and thus represents a druggable pathway to treat antibody-mediated autoimmunity.

21 March 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TNTina Nguyen
Tina Nguyen
ALAnthony Lau
Anthony Lau
JBJulia Bier
Julia Bier
KCKristen C. Cooke
Kristen C. Cooke
HLHelen Lenthall
Helen Lenthall
EDElissa K. Deenick
Elissa K. Deenick
Heterozygous loss-of-function (LOF) mutations in PIK3R1 (encoding phosphatidylinositol 3-kinase [PI3K] regulatory subunits) cause activated PI3Kδ syndrome 2 (APDS2), which has a similar clinical profile to APDS1, caused by heterozygous gain-of-function (GOF) mutations in PIK3CD (encoding the PI3K p110δ catalytic subunit). While several studies have established how PIK3CD GOF leads to immune dysregulation, less is known about how PIK3R1 LOF mutations alter cellular function. By studying a novel CRISPR/Cas9 mouse model and patients’ immune cells, we determined how PIK3R1 LOF alters cellular function. We observed some overlap in cellular defects in APDS1 and APDS2, including decreased intrinsic B cell class switching and defective Tfh cell function. However, we also identified unique APDS2 phenotypes including defective expansion and affinity maturation of Pik3r1 LOF B cells following immunization, and decreased survival of Pik3r1 LOF pups. Further, we observed clear differences in the way Pik3r1 LOF and Pik3cd GOF altered signaling. Together these results demonstrate crucial differences between these two genetic etiologies.

1 November 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
AKAlisa Kane
Alisa Kane
ALAnthony Lau
Anthony Lau
RBRobert Brink
Robert Brink
STStuart G. Tangye
Stuart G. Tangye
EDElissa K. Deenick
Elissa K. Deenick